Perspectives for metabolomics in testosterone replacement therapy
Author:
- 30 April 2012
- journal article
- review article
- Published by Bioscientifica in Journal of Endocrinology
- Vol. 215 (1) , 3-16
Abstract
Testosterone is the major circulating androgen in men but exhibits an age-related decline in the ageing male. Late-onset hypogonadism or androgen deficiency syndrome (ADS) is a ‘syndromic’ disorder including both a persistent low testosterone serum concentration and major clinical symptoms, including erectile dysfunction, low libido, decreased muscle mass and strength, increased body fat, decreased vitality or depressed mood. Given its unspecific symptoms, treatment goals and monitoring parameters, this review will outline the various uncertainties concerning the diagnosis, therapy and monitoring of ADS to date. Literature was identified primarily through searches for specific investigators in the PubMed database. No date or language limits were applied in the literature search for the present review. The current state of research, showing that metabolomics is starting to have an impact not only on disease diagnosis and prognosis but also on drug treatment efficacy and safety monitoring, will be presented, and the application of metabolomics to improve the clinical management of ADS will be discussed. Finally, the scientific opportunities presented by metabolomics and other -omics as novel and promising tools for biomarker discovery and individualised testosterone replacement therapy in men will be explored.Keywords
This publication has 133 references indexed in Scilit:
- Personal Omics Profiling Reveals Dynamic Molecular and Medical PhenotypesCell, 2012
- Genome-wide association study identifies multiple loci influencing human serum metabolite levelsNature Genetics, 2012
- Stability and Robustness of Human Metabolic Phenotypes in Response to Sequential Food ChallengesJournal of Proteome Research, 2011
- A role for systems epidemiology in tuberculosis researchTrends in Microbiology, 2011
- Human metabolic profiles are stably controlled by genetic and environmental variationMolecular Systems Biology, 2011
- Welcoming low testosterone as a cardiovascular risk factorInternational Journal Of Impotence Research, 2009
- Metabolomic profiles delineate potential role for sarcosine in prostate cancer progressionNature, 2009
- Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivityMolecular Systems Biology, 2008
- Application of Metabolomics to Cardiovascular Biomarker and Pathway DiscoveryJACC, 2008
- 1H NMR metabonomics approach to the disease continuum of diabetic complications and premature deathMolecular Systems Biology, 2008